{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:19:38Z","timestamp":1791119978352,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":1832,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1038\/ki.2010.427","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T08:09:03Z","timestamp":1291104543000},"page":"S71-S75","source":"Crossref","is-referenced-by-count":16,"special_numbering":"S119","title":["Non-immune interventions to protect kidney allografts in the long term"],"prefix":"10.1016","volume":"78","author":[{"given":"Paolo","family":"Cravedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norberto","family":"Perico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2010.427_bb0010","first-page":"1","article-title":"Thirty year trend in kidney transplants: UCLA and UNOS Renal Transplant Registry","author":"Kaneku","year":"2006","journal-title":"Clin Transpl"},{"key":"10.1038\/ki.2010.427_bb0015","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1681\/ASN.V971321","article-title":"Protecting single-kidney allografts from long-term functional deterioration","volume":"9","author":"Remuzzi","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.427_bb0020","first-page":"F324","article-title":"Nephron adaptation to renal injury or ablation","volume":"249","author":"Brenner","year":"1985","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2010.427_bb0025","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00007890-199702270-00006","article-title":"Nephron mass modulates the hemodynamic, cellular, and molecular response of the rat renal allograft","volume":"63","author":"Azuma","year":"1997","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.427_bb0030","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.427_bb0035","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2215\/CJN.00340107","article-title":"Sirolimus: defining nephrotoxicity in the renal transplant recipient","volume":"2","author":"Tomlanovich","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.427_bb0040","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1172\/JCI27699","article-title":"Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes","volume":"116","author":"Remuzzi","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2010.427_bb0045","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1524-6175.2007.06588.x","article-title":"Hypertension after renal transplant","volume":"9","author":"Tedla","year":"2007","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1038\/ki.2010.427_bb0050","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1681\/ASN.V11suppl_1s1","article-title":"Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation","volume":"15","author":"Kasiske","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.427_bb0055","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s11906-001-0063-1","article-title":"Hypertension after renal transplantation","volume":"3","author":"Schwenger","year":"2001","journal-title":"Curr Hypertens Rep"},{"key":"10.1038\/ki.2010.427_bb0060","doi-asserted-by":"crossref","first-page":"S243","DOI":"10.1681\/ASN.V212s243","article-title":"Cyclosporine and posttransplant hypertension","volume":"2","author":"Curtis","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.427_bb0065","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jama.283.5.633","article-title":"Arterial hypertension and renal allograft survival","volume":"283","author":"Mange","year":"2000","journal-title":"JAMA"},{"key":"10.1038\/ki.2010.427_bb0070","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1053\/ajkd.2000.16225","article-title":"Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group","volume":"36","author":"Bakris","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2010.427_bb0075","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.jhh.1001770","article-title":"Effect of lifestyle modifications on blood pressure by race, sex, hypertension status, and age","volume":"19","author":"Svetkey","year":"2005","journal-title":"J Hum Hypertens"},{"issue":"Suppl 1","key":"10.1038\/ki.2010.427_bb0080","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1111\/tri.1992.5.s1.69","article-title":"Nifedipine improves immediate, and 6- and 12-month graft function in cyclosporin A (CyA) treated renal allograft recipients","volume":"5","author":"Harper","year":"1992","journal-title":"Transpl Int"},{"key":"10.1038\/ki.2010.427_bb0085","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.427_bb0090","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"10.1038\/ki.2010.427_bb0095","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1001\/jama.285.21.2719","article-title":"Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial","volume":"285","author":"Agodoa","year":"2001","journal-title":"JAMA"},{"key":"10.1038\/ki.2010.427_bb0100","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.amjmed.2008.02.038","article-title":"Angiotensin receptor blockers: current status and future prospects","volume":"121","author":"Ram","year":"2008","journal-title":"Am J Med"},{"key":"10.1038\/ki.2010.427_bb0105","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa042739","article-title":"Angiotensin-converting-enzyme inhibition in stable coronary artery disease","volume":"351","author":"Braunwald","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.427_bb0110","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","article-title":"Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)","volume":"349","author":"Ruggenenti","year":"1997","journal-title":"Lancet"},{"key":"10.1038\/ki.2010.427_bb0115","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s11906-007-0077-4","article-title":"Is RAS blockade routinely indicated in hypertensive kidney transplant patients?","volume":"9","author":"Salzberg","year":"2007","journal-title":"Curr Hypertens Rep"},{"key":"10.1038\/ki.2010.427_bb0120","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/01.tp.0000235527.81917.fe","article-title":"Cardiovascular complications after renal transplantation and their prevention","volume":"82","author":"Ojo","year":"2006","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.427_bb0125","first-page":"1235","article-title":"Proteinuria in renal transplant recipients: incidence, cause, prognostic importance","volume":"20","author":"Bear","year":"1988","journal-title":"Transplant Proc"},{"issue":"Suppl 8","key":"10.1038\/ki.2010.427_bb0130","first-page":"viii61","article-title":"Sirolimus in renal transplantation","volume":"22","author":"Morath","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2010.427_bb0135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ndt\/gfi265","article-title":"Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases","volume":"21","author":"Ruiz-Ortega","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2010.427_bb0140","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.amjmed.2003.09.034","article-title":"The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease","volume":"116","author":"Brewster","year":"2004","journal-title":"Am J Med"},{"key":"10.1038\/ki.2010.427_bb0145","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1046\/j.1523-1755.2003.00318.x","article-title":"ACE inhibition limits chronic injury of kidney transplant even with treatment started when lesions are established","volume":"64","author":"Noris","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.427_bb0150","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1681\/ASN.2005090955","article-title":"Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation","volume":"17","author":"Heinze","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.427_bb0155","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1111\/j.1600-6143.2007.01928.x","article-title":"Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence","volume":"7","author":"Hiremath","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2010.427_bb0160","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.427_bb0165","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/ndt\/gfm574","article-title":"The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation\u2014study design","volume":"23","author":"Knoll","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2010.427_bb0170","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1159\/000144024","article-title":"Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatment","volume":"28","author":"Tsimihodimos","year":"2008","journal-title":"Am J Nephrol"},{"issue":"Suppl 3","key":"10.1038\/ki.2010.427_bb0175","first-page":"iii67","article-title":"The effects of hyperlipidaemia on graft and patient outcome in renal transplantation","volume":"19","author":"Del Castillo","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2010.427_bb0180","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nrd2685","article-title":"Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection","volume":"7","author":"Perico","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1038\/ki.2010.427_bb0185","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(03)13638-0","article-title":"Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial","volume":"361","author":"Holdaas","year":"2003","journal-title":"Lancet"},{"key":"10.1038\/ki.2010.427_bb0190","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/j.1523-1755.2004.00919.x","article-title":"Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial","volume":"66","author":"Fellstrom","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.427_bb0195","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/TP.0b013e318174428d","article-title":"Fluvastatin in the prevention of renal transplant vasculopathy: results of a prospective, randomized, double-blind, placebo-controlled trial","volume":"86","author":"Seron","year":"2008","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.427_bb0200","first-page":"44","article-title":"Identification of medication-adherence barriers and strategies to increase adherence in recipients of renal transplants","volume":"17","author":"Chisholm","year":"2004","journal-title":"Manag Care Interface"},{"key":"10.1038\/ki.2010.427_bb0205","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1600-6143.2004.00537.x","article-title":"Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients","volume":"4","author":"Vlaminck","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2010.427_bb0210","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1440-172X.2008.00710.x","article-title":"Compliance of kidney transplant patients to the recommended lifestyle behaviours: single centre experience","volume":"14","author":"Gheith","year":"2008","journal-title":"Int J Nurs Pract"},{"key":"10.1038\/ki.2010.427_bb0215","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.transproceed.2003.11.051","article-title":"Cigarette smoking in renal transplant recipients","volume":"36","author":"Yavuz","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1038\/ki.2010.427_bb0220","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11906-007-0012-8","article-title":"Cigarette smoking as a risk factor for atherosclerosis and renal disease: novel pathogenic insights","volume":"9","author":"Mercado","year":"2007","journal-title":"Curr Hypertens Rep"},{"key":"10.1038\/ki.2010.427_bb0225","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.transproceed.2004.06.065","article-title":"Nutrition for the post-renal transplant recipients","volume":"36","author":"Martins","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1038\/ki.2010.427_bb0230","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1681\/ASN.2007111202","article-title":"Sirolimus is associated with new-onset diabetes in kidney transplant recipients","volume":"19","author":"Johnston","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.427_bb0235","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.transproceed.2005.12.106","article-title":"Posttransplant diabetes mellitus: impact of good blood glucose regulation on renal transplant recipient outcome","volume":"38","author":"Sezer","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1038\/ki.2010.427_bb0240","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1681\/ASN.2007090970","article-title":"Role of remission clinics in the longitudinal treatment of CKD","volume":"19","author":"Ruggenenti","year":"2008","journal-title":"J Am Soc Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815544840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815544840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T06:21:19Z","timestamp":1636870879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815544840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":47,"alternative-id":["S0085253815544840"],"URL":"https:\/\/doi.org\/10.1038\/ki.2010.427","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}